Knight Therapeutics Inc.
KHTRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,332 | -$16,835 | -$29,892 | $15,675 |
| Dep. & Amort. | $53,109 | $50,397 | $62,621 | $47,915 |
| Deferred Tax | -$3,243 | -$9,126 | -$17,125 | -$7,636 |
| Stock-Based Comp. | $1,860 | $2,327 | $1,888 | $3,045 |
| Change in WC | -$19,624 | -$5,545 | -$9,989 | $627 |
| Other Non-Cash | -$154 | $14,721 | $32,978 | -$15,008 |
| Operating Cash Flow | $36,280 | $35,939 | $40,481 | $44,618 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,469 | -$950 | -$25,816 | -$224,183 |
| Net Acquisitions | $0 | $0 | $0 | -$220,351 |
| Inv. Purchases | -$162,570 | -$334,163 | -$185,473 | -$64,321 |
| Inv. Sales/Matur. | $210,808 | $347,901 | $150,544 | $180,541 |
| Other Inv. Act. | -$28,806 | $16,553 | -$2,334 | $223,035 |
| Investing Cash Flow | $16,963 | $29,341 | -$63,079 | -$105,279 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$18,051 | -$18,024 | $31,491 | -$14,192 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$8,866 | -$53,479 | -$30,069 | -$64,415 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,623 | -$9,499 | -$4,179 | $297 |
| Financing Cash Flow | -$33,540 | -$81,002 | $1,762 | -$78,310 |
| Forex Effect | $1,642 | $2,804 | $6,552 | -$4,658 |
| Net Chg. in Cash | $21,345 | -$12,918 | -$14,284 | -$143,629 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $58,761 | $71,679 | $85,963 | $229,592 |
| End Cash | $80,106 | $58,761 | $71,679 | $85,963 |
| Free Cash Flow | $4,808 | $25,981 | $14,665 | -$179,565 |